Evidence map›Paper›PMID 40579699›Full record

ArticleCell & bioscience2025

Single-cell and spatial analyses of the GDF family in tumors, with a focus on the prognostic and biological role of GDF15 in hepatocellular carcinoma.

Xiaoqian Feng, Qian Huai, Fumin Zhang, Wenkang Yuan, Xingyu Li, Zhuo Yu, Hao Zhang, Yaoling Zhu, Xu Zhang, Baole Tao and 2 more

Abstract read
In one paragraph

Article in Cell & bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaoqian Feng *Department of Laboratory Medicine, the First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, China.
Qian Huai *Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Fumin Zhang *Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Wenkang Yuan *Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Xingyu LiDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zhuo YuDepartment of Radiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Hao ZhangDepartment of Anesthesiology, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, 230041, China.
Yaoling ZhuChaohu Clinical Medical College, Anhui Medical University, Hefei, 230601, China.
Xu ZhangDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Baole TaoThe Affiliated High School of Peking University, Beijing, 100080, China.
Ying DaiDepartment of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. dabora20051@hotmail.com.
Yishan DuThe First Affiliated Hospital of Ningbo University, Ningbo, 117881, China. duysh95@163.com.ORCID http://orcid.org/0000-0002-7125-2569

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth differentiation factors (GDFs) are a subfamily of the TGF-β superfamily whose expression increases in response to cellular stress and disease. Despite emerging cell- or animal-based evidence supporting an association between the GDF subfamily and cancer, systematic pan-cancer analyses of the GDF subfamily based on single-cell and spatial transcriptomes remains unavailable. In this study, we performed a comprehensive analysis of the GDF subfamily in 33 cancers, including expression, diagnosis, methylation, prognostic value, immune infiltration analysis, and potential biological pathways. We focused on the analysis of multi-group scRNA-seq and spatial data in hepatocellular carcinoma (HCC) to determine the role of the GDF family in the tumor microenvironment and its applicability in immunotherapy. Moreover, both the gain and loss of function strategies were used to assess the function of Growth differentiation factor 15 (GDF15) in cell lines of HCC. The GDF subfamily is expressed to varying degrees in most tumors and is significantly correlated with the prognosis of cancer patients. Subsequent scRNA-seq analysis depicted the heterogeneous cellular ecosystems of normal liver and HCC. Hepatocytes expressing GDF15 were less differentiated in HCC, and GDF15 promoted proliferation and invasion of HCC cell lines. Compared to normal liver, the strength of crosstalk between GDF15-positive Hepatocytes and other cells was enhanced in tumors, especially cancer-associated fibroblasts (CAFs)-derived Periostin and GDF15-positive Hepatocytes both regulate each other and jointly promote hepatocarcinogenesis. Further spatial transcriptomic data showed that GDF15 expression was negatively correlated with immune infiltration, especially in M1-type macrophages. Notably, validation analyses in bulk RNA-seq consistently emphasized the clinical significance of these findings. This study provides a comprehensive overview of the oncogenic role of the GDF subfamily in a wide range of tumors, highlights the important role of GDF15 in HCC ecosystem, and provides important biomarkers and potential therapeutic targets for future research.

Indexed as

Clinical significanceDiagnosisGrowth differentiation factor15Growth differentiation factors subfamilyImmune infiltrationPrognostic biomarker

Identifiers

PMID40579699
PMCPMC12205498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.